Global Herpes Simplex Virus Treatment Market, By Type (Herpes Simplex Virus - Type 1, Herpes Simplex Virus - Type 2), Drugs (Acyclovir, Famciclovir, Valacyclovir, Others), Vaccine (GEN-003, HSV529, VCL-HB01, Others), Diagnosis (Blood Tests, Laboratory Tests, HSV Testing, Others), Route of Administration (Oral, Intravenous, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028